Comparison of basal gene expression and induction of CYP3As in HepG2 and human fetal liver cells

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 11, 2007, Pages 2091-2097

  Maruyama, Masataka ^a   Matsunaga, Tamihide ^a   Harada, Eri ^a   Ohmori, Shigeru ^a  

^a SHINSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

CYP3A4; CYP3A7; Glucocorticoid receptor; HepG2 cell; Human fetal liver cell; Induction

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALBUMIN; ALPHA FETOPROTEIN; CYTOCHROME P450 1A2; CYTOCHROME P450 2A6; CYTOCHROME P450 2B6; CYTOCHROME P450 2C; CYTOCHROME P450 2C19; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; CYTOCHROME P450 3A7; DEXAMETHASONE; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; MESSENGER RNA; PREGNANE X RECEPTOR; RIFAMPICIN; SCATTER FACTOR;

ARTICLE; CELL COUNT; CELL CULTURE; CELL PROLIFERATION; CELL STRAIN HEPG2; CELL VIABILITY; CONTROLLED STUDY; ENZYME INDUCTION; FETUS LIVER; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER CELL;

ARYL HYDROCARBON HYDROXYLASES; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CYTOCHROME P-450 ENZYME SYSTEM; DEXAMETHASONE; ENZYME INDUCTION; FETUS; FORMAZANS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPATOCYTES; HUMANS; ISOENZYMES; LIVER NEOPLASMS; RNA, MESSENGER; TETRAZOLIUM SALTS; TIME FACTORS;

EID: 36048970543     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.2091     Document Type: Article

References (42)

1. Nelson D. R., Koymans L., Kamataki T., Stegeman J. J., Feyereisen R., Waxman D. J., Waterman M. R., Gotoh O., Coon M. J., Estabrook R. W., Gunsalus I. C., Nebert D. W., Pharmacogenetics, 6, 1-42 (1996).
2. Shimada T., Yamazaki H., Mimura M., Inui Y., Guengerich F. P., J. Pharmacol. Exp. Ther., 270, 414-423 (1994).
3. Kolars J. C., Lown K. S., Schmiedlin-Ren P., Ghosh M., Fang C., Wrighton S. A., Merion R. M., Watkins P. B., Pharmacogenetics, 4, 247-259 (1994).
4. Guengerich F. P., Annu. Rev. Pharmacol. Toxicol., 39, 1-17 (1999).
5. Schuetz J. D., Beach D. L., Guzelian P. S., Pharmacogenetics, 4, 11-20 (1994).
6. Kuehl P., Zhang J., Lin Y., Lamba J., Assem M., Schuetz J., Watkins P. B., Daly A., Wrighton S. A., Hall S. D., Maurel P., Relling M., Brimer C., Yasuda K., Venkataramanan R., Strom S., Thummel K., Boguski M. S., Schuetz E., Nat. Genet., 27, 383-391 (2001).
7. Stevens J. C., Hines R. N., Gu C., Koukouritaki S. B., Manro J. R., Tandler P. J., Zaya M. J., J. Pharmacol. Exp. Ther., 307, 573-582 (2003).
8. Meunier V., Bourrie M., Julian B., Marti E., Guillou F., Berger Y., Fabre G., Xenobiotica, 30, 589-607 (2000).
9. Luo G., Cunningham M., Kim S., Burn T., Lin J., Sinz M., Hamilton G., Rizzo C., Jolley S., Gilbert D., Downey A., Mudra D., Graham R., Carroll K., Xie J., Madan A., Parkinson A., Christ D., Selling B., LeCluyse E., Gan L. S., Drug Metab. Dispos., 30, 795-804 (2002).
10. Madan A., Graham R. A., Carroll K. M., Mudra D. R., Burton L. A., Krueger L. A., Downey A. D., Czerwinski M., Forster J., Ribadeneira M. D., Gan L. S., LeCluyse E. L., Zech K., Robertson P., Jr., Koch P., Antonian L., Wagner G., Yu L., Parkinson A., Drug Metab. Dispos., 31, 421-431 (2003).
11. Wrighton S. A., Vandenbranden M., Arch. Biochem. Biophys., 268, 144-151 (1989).
12. Okey A. B., Pharmacol. Ther., 45, 241-298 (1990).
13. Boocock D. J., Maggs J. L., Brown K., White I. N., Park B. K., Carcinogenesis, 21, 1851-1858 (2000).
14. Gibson G. G., Plant N. J., Swales K. E., Ayrton A., El-Sankary W., Xenobiotica, 32, 165-206 (2002).
15. Sumida A., Fukuen S., Yamamoto I., Matsuda H., Naohara M., Azuma J., Biochem. Biophys. Res. Commun., 267, 756-760 (2000).
16. Aden D. P., Fogel A., Plotkin S., Damjanov I., Knowles B. B., Nature (London), 282, 615-616 (1979).
17. Schuetz E. G., Schuetz J. D., Strom S. C., Thompson M. T., Fisher R. A., Molowa D. T., Li D., Guzelian P. S., Hepatology, 18, 1254-1262 (1993).
18. Sugihara N., Ise H., Negishi N., Nikaido T., Akaike T., Cell Biochem. Funct., 20, 11-17 (2002).
19. Jones E. A., Clement-Jones M., James O. F., Wilson D. I., J. Anat., 198, 555-559 (2001).
20. Lavon N., Yanuka O., Benvenisty N., Differentiation, 72, 230-238 (2004).
21. Tirona R. G., Lee W., Leake B. F., Lan L., Cline C. B., Lamba V., Parviz F., Duncan S. A., Inoue Y., Gonzalez F. J., Schuetz E. G., Kim R. B., Nature Med., 9, 220-224 (2003).
22. Strom S. C., Pisarov L. A., Dorko K., Thompson M. T., Schuetz J. D., Schuetz E. G., Methods Enzymol., 272, 388-401 (1996).
23. Li A. P., Maurel P., Gomez-Lechon M. J., Cheng L. C., Jurima-Romet M., Chem. Biol. Interact., 107, 5-16 (1997).
24. Matsunaga T., Maruyama M., Harada E., Katsuyama Y., Sugihara N., Ise H., Negishi N., Ikeda U., Ohmori S., Biochem. Biophys. Res. Commun., 318, 428-434 (2004).
25. Sumida A., Yamamoto I., Zhou Q., Morisaki T., Azuma J., Biol. Pharm. Bull., 22, 61-65 (1999).
26. Lazaro C. A., Croager E. J., Mitchell C., Campbell J. S., Yu C., Foraker J., Rhim J. A., Yeoh G. C., Fausto N., Hepatology, 38, 1095-1106 (2003).
27. Leeder J. S., Gaedigk R., Marcucci K. A., Gaedigk A., Vyhlidal C. A., Schindel B. P., Pearce R. E., J. Pharmacol. Exp. Ther., 314, 626-635 (2005).
28. Maurel P., Adv. Drug Deliver. Rev., 22, 105-132 (1996).
29. Nishimura M., Yoshitsugu H., Naito S., Hiraoka I., Yakugaku Zasshi, 122, 339-361 (2002).
30. Derman E., Krauter K., Walling L., Weinberger C., Ray M., Darnell J. E., Jr., Cell, 23, 731-739 (1981).
31. Panduro A., Shalaby F., Shafritz D. A., Hepatology, 7, 10S-18S (1987).
32. Tilghman S. M., Belayew, A., Proc. Natl. Acad. Sci. U.S.A., 79, 5254-5257 (1982).
33. Rodriguez-Antona C., Donato M. T., Boobis A., Edwards R. J., Watts P. S., Castell J. V., Gomez-Lechon M. J., Xenobiotica, 32, 505-520 (2002).
34. Ogino M., Nagata K., Yamazoe Y., Drug Metab. Pharmacokinet., 17, 42-46 (2002).
35. Usui T., Saitoh Y., Komada F., Biol. Pharm. Bull., 26, 510-517 (2003).
36. Hewitt N. J., Hewitt P., Xenobiotica, 34 243-256 (2004).
37. Lehmann J. M., McKee D. D., Watson M. A., Willson T. M., Moore J. T., Kliewer S. A., J. Clin. Invest., 102, 1016-1023 (1998).
38. Pascussi J. M., Drocourt L., Fabre J. M., Maurel P., Vilarem M. J., Mol. Pharmacol., 58, 361-372 (2000).
39. Pascussi J. M., Gerbal-Chaloin S., Fabre J. M., Maurel P., Vilarem M. J., Mol. Pharmacol., 58, 1441-1450 (2000).
40. Yaffe S. J., Rane A., Sjoqvist F., Boreus L. O., Orrenius S., Life Sci., 9, 1189-1200 (1970).
41. Kitada M., Yakugaku Zasshi, 111, 158-169 (1991).
42. Ring J. A., Ghabrial H., Ching M. S., Smallwood R. A., Morgan D. J., Pharmacol. Ther., 84, 429-445 (1999).